Clin2
NCT06956144Likely a fitRecruiting

CAIX-targeted PET scan for kidney cancer

TumorCarbonic Anhydrase IX

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial uses a special PET scan that targets a protein (CAIX) often found in kidney cancer cells. It helps doctors see the cancer more clearly, which may guide better treatment decisions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
113 people
Ages
18 years to 74 years
Study type
Observational

Who can take part

  • You must be 18 to 75 years old.
  • You have suspected or confirmed kidney cancer (clear cell, papillary, or chromophobe type).
  • You have had an enhanced CT scan in the last 2 weeks.
  • Your blood test results show your liver and kidney function are within safe limits.
  • You are willing to have a biopsy if you haven't already.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06519760Recruiting
68Ga-C1 PET/CT imaging for clear cell kidney cancer

This trial uses a special imaging scan (68Ga-C1 PET/CT) to see kidney cancer more clearly. It helps doctors find and understand clear cell renal cell carcinoma, a common type of kidney cancer.

Beijing, Beijing Municipality
NCT07590310Recruiting· Early Phase 1
CAIX-Targeted PET Imaging Scan for Tumor Diagnosis

This early-stage trial tests a new type of imaging scan (called PET) that uses a special tracer to help doctors see tumors better. The scan targets a protein called CAIX that appears on many cancer cells, which may help with accurate diagnosis and staging.

Beijing, Haidian
NCT07875946Not yet recruiting· Early Phase 1
PET imaging for kidney cancer

This trial tests a new PET imaging agent that may help detect and evaluate kidney masses suspected to be kidney cancer, including early or recurring cases. It could help doctors better understand the tumor before deciding on treatment.

Beijing, Beijing Municipality
NCT07301827Recruiting
New PET imaging for kidney cancer diagnosis

This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.

Wuhan, Hubei
NCT07833085Recruiting
Imaging test for solid tumors using a special tracer

This study tests a new imaging method that uses a special tracer to find solid tumors in the body. It may help doctors see tumors more clearly and guide treatment.

Wuhan, Hubei
NCT07101900Enrolling by invitation· Phase 2
Better imaging for kidney cancer before surgery

This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.

Beijing, Beijing Municipality

Hear when a new Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.